Wednesday, August 15, 2012


Hemispherx Biopharma, manufacturer of Ampligen, has announced that the FDA has accepted its revised application as complete. A decision on marketing approval for Ampligen as a treatment for CFS is expected by Feb. 2, 2013, according to regulations that guide FDA. From RTT News:

No comments: